Clinically and Microbiologically Derived Azithromycin Susceptibility Breakpoints for Salmonella enterica Serovars Typhi and Paratyphi A

Azithromycin is an effective treatment for uncomplicated infections with Salmonella enterica serovar Typhi and serovar Paratyphi A (enteric fever), but there are no clinically validated MIC and disk zone size interpretative guidelines. We studied individual patient data from three randomized control...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Parry, Christopher M., Thieu, Nga Tran Vu, Dolecek, Christiane, Karkey, Abhilasha, Gupta, Ruchi, Turner, Paul, Dance, David, Maude, Rapeephan R., Ha, Vinh, Tran, Chinh Nguyen, Thi, Phuong Le, Be, Bay Pham Van, Phi, La Tran Thi, Ngoc, Rang Nguyen, Ghose, Aniruddha, Dongol, Sabina, Campbell, James I., Thanh, Duy Pham, Thanh, Tuyen Ha, Moore, Catrin E., Sona, Soeng, Gaind, Rajni, Deb, Monorama, Anh, Ho Van, Van, Sach Nguyen, Tinh, Hien Tran, Day, Nicholas P. J., Dondorp, Arjen, Thwaites, Guy, Faiz, Mohamed Abul, Phetsouvanh, Rattanaphone, Newton, Paul, Basnyat, Buddha, Farrar, Jeremy J., Baker, Stephen
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2015
Assuntos:
Susceptibility
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394775/
https://ncbi.nlm.nih.gov/pubmed/25733500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04729-14
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares